Literature DB >> 22403310

Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera.

Cristina Riera1, Mireia Verges, Laura Iniesta, Roser Fisa, Montserrat Gállego, Silvia Tebar, Montserrat Portús.   

Abstract

A Western blot (WB) method using a lysate from Trypanosoma cruzi (Maracay strain) epimastigotes was evaluated. Serum samples from 37 patients with confirmed Chagas disease (cohort I), 27 Spanish patients with visceral leishmaniasis caused by Leishmania infantum (cohort II), and 28 Colombian patients with cutaneous leishmaniasis caused by L. panamensis and negative serology for Chagas disease (cohort III) were tested. The negative controls were 55 healthy seronegative subjects for T. cruzi and Leishmania; 28 of the negative controls were from a region endemic for Chagas disease and Leishmania (cohort IV), and 27 of the negative controls were from a non-endemic area for Leishmania and T. cruzi (cohort V). A homogeneous standard band pattern consisting of six antigenic bands corresponding to 28, 32, 38, 39, 40, and 48 kDa was recognized simultaneously for all Chagasic patients' sera. Sera from Leishmania-infected patients showed a heterogeneous band pattern that was easily differentiated from the pattern of patients with Chagas disease. WB with T. cruzi epimastigote antigen is an efficient method for diagnosis and may be used as an alternative to confirm T. cruzi and detect cross-reactivity with Leishmania.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22403310      PMCID: PMC3284355          DOI: 10.4269/ajtmh.2012.11-0111

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  30 in total

1.  Identification of immunodominant antigens in Mexican strains of Trypanosoma cruzi.

Authors:  M I Bucio; M Cabrera; E L Segura; E Zenteno; M Salazar-Schettino
Journal:  Immunol Invest       Date:  1999-07       Impact factor: 3.657

2.  Analysis of Trypanosoma cruzi antigens bound by specific antibodies and by antibodies to related trypanosomatids.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

3.  Immunoenzymatic assy (ELISA) in mucocutaneous leishmaniasis, kala-azar, and Chagas' disease: an epimastigote Trypanosoma cruzi antigen able to distinguish between anti-Trypanosoma and anti-Leishmania antibodies.

Authors:  M C Guimarães; B J Celeste; E A de Castilho; J R Mineo; J M Diniz
Journal:  Am J Trop Med Hyg       Date:  1981-09       Impact factor: 2.345

4.  Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate.

Authors:  C Riera; J E Valladares; M Gállego; M J Aisa; S Castillejo; R Fisa; N Ribas; J Carrió; J Alberola; M Arboix
Journal:  Vet Parasitol       Date:  1999-07       Impact factor: 2.738

5.  Evaluation of antibody responses in American visceral leishmaniasis by ELISA and immunoblot.

Authors:  T G Evans; E C Krug; M E Wilson; A W Vasconcelos; J E de Alencar; R D Pearson
Journal:  Mem Inst Oswaldo Cruz       Date:  1989 Apr-Jun       Impact factor: 2.743

6.  Antibody maturation in Trypanosoma cruzi-infected rats.

Authors:  I S Marcipar; M G Risso; A M Silber; S Revelli; A J Marcipar
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

7.  Chagas disease: a Latin American health problem becoming a world health problem.

Authors:  Gabriel A Schmunis; Zaida E Yadon
Journal:  Acta Trop       Date:  2009-11-20       Impact factor: 3.112

8.  Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).

Authors:  E L Malchiodi; M G Chiaramonte; N J Taranto; N W Zwirner; R A Margni
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

9.  Evaluation of antigens from various Leishmania species in a Western blot for diagnosis of American tegumentary leishmaniasis.

Authors:  Cely Cristina Martins Gonçalves; Edna Maria Vissoci Reiche; Benício Alves De Abreu Filho; Thais Gomes Verzignassi Silveira; Tânia Cristina Felizardo; Karoline Rocha Maia; Rafael Costacurta; Evandro José Padovesi; Benedito Prado Dias Filho; Shiduca Itow Jankevicius; José Vitor Jankevicius
Journal:  Am J Trop Med Hyg       Date:  2002-01       Impact factor: 2.345

10.  Development and evaluation of an enzyme linked immunotransfer blot technique for serodiagnosis of Chagas' disease.

Authors:  M G Teixeira; J Borges-Pereira; E Netizert; M L Souza; J M Peralta
Journal:  Trop Med Parasitol       Date:  1994-12
View more
  11 in total

1.  Influence of Fatty Acid Modification on Uptake of Lovastatin-Loaded Reconstituted High Density Lipoprotein by Foam Cells.

Authors:  Yun Yang; Ji Wang; Hongliang He; Wenli Zhang; Yuansheng Zhang; Jianping Liu
Journal:  Pharm Res       Date:  2018-05-07       Impact factor: 4.200

2.  Serological Diagnosis of Chronic Chagas Disease: Is It Time for a Change?

Authors:  Alba Abras; Montserrat Gállego; Teresa Llovet; Silvia Tebar; Mercedes Herrero; Pere Berenguer; Cristina Ballart; Carmen Martí; Carmen Muñoz
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

3.  Towards a New Strategy for Diagnosis of Congenital Trypanosoma cruzi Infection.

Authors:  Alba Abras; Carmen Muñoz; Cristina Ballart; Pere Berenguer; Teresa Llovet; Mercedes Herrero; Silvia Tebar; María-Jesús Pinazo; Elizabeth Posada; Carmen Martí; Victoria Fumadó; Jordi Bosch; Oriol Coll; Teresa Juncosa; Gemma Ginovart; Josep Armengol; Joaquim Gascón; Montserrat Portús; Montserrat Gállego
Journal:  J Clin Microbiol       Date:  2017-02-15       Impact factor: 5.948

4.  Toxic Profile of Benznidazole in Patients with Chronic Chagas Disease: Risk Factors and Comparison of the Product from Two Different Manufacturers.

Authors:  I Molina; F Salvador; A Sánchez-Montalvá; B Treviño; N Serre; A Sao Avilés; B Almirante
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

5.  Assessment of rectocolonic morphology and function in patients with Chagas disease in Barcelona (Spain).

Authors:  Fernando Salvador; Marianela Mego; Adrián Sánchez-Montalvá; María Morís; Kathleen Ramírez; Ana Accarino; Juan-Ramon Malagelada; Fernando Azpiroz; Israel Molina
Journal:  Am J Trop Med Hyg       Date:  2015-03-16       Impact factor: 2.345

Review 6.  Critical analysis of Chagas disease treatment in different countries.

Authors:  Fernanda de Souza Nogueira Sardinha Mendes; Jose Antonio Perez-Molina; Andrea Angheben; Sheba K Meymandi; Sergio Sosa-Estani; Israel Molina
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-07-08       Impact factor: 2.747

Review 7.  Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.

Authors:  Carmen Muñoz; Montserrat Gállego; Alba Abras; Cristina Ballart; Anna Fernández-Arévalo; María-Jesús Pinazo; Joaquim Gascón
Journal:  Clin Microbiol Rev       Date:  2022-03-03       Impact factor: 50.129

8.  Congenital transmission of Trypanosoma cruzi in non-endemic areas: evaluation of a screening program in a tertiary care hospital in Barcelona, Spain.

Authors:  Susana Otero; Elena Sulleiro; Israel Molina; Maria Espiau; Anna Suy; Andrea Martín-Nalda; Concepción Figueras
Journal:  Am J Trop Med Hyg       Date:  2012-09-17       Impact factor: 2.345

9.  Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain.

Authors:  Fernando Salvador; Israel Molina; Elena Sulleiro; Joaquín Burgos; Adrián Curran; Eva Van den Eynde; Sara Villar del Saz; Jordi Navarro; Manuel Crespo; Inma Ocaña; Esteve Ribera; Vicenç Falcó; Albert Pahissa
Journal:  Am J Trop Med Hyg       Date:  2013-03-18       Impact factor: 2.345

10.  Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic.

Authors:  Daniel Guzmán-Gómez; Aracely López-Monteon; María de la Soledad Lagunes-Castro; Carolina Álvarez-Martínez; Manuel Jesús Hernández-Lutzon; Eric Dumonteil; Angel Ramos-Ligonio
Journal:  Parasit Vectors       Date:  2015-09-17       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.